MedPath

Pilot Study to Investigate Complaints, Wellbeing and Hormone Levels before and after Participation in a Hormone-Yoga Class for 10 Weeks

Not Applicable
Conditions
E28
N95
Ovarian dysfunction
Menopausal and other perimenopausal disorders
Registration Number
DRKS00010733
Lead Sponsor
niversitätsklinikum HeidelbergAmbulanz für Naturheilkunde der Abt. Gynäkolog. Endokrinologie und Fertilitätsstörungen Universitätsfrauenklinik
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Female
Target Recruitment
50
Inclusion Criteria

Registered participants with potentially hormone- related symptoms interested in learning a self- applicable method with potential influence on complaints, well-being and hormone levels of the course: Hormone-yoga class offered by the department Gynaecological Endocrinology and Fertility Disorders
• Minimum age 18 years
• Willingness for regular participation in 10 weekly lessons
• Willingness for 2-6 self-initiated home practice sessions of 30 minutes/week during the duration of the course
• Ability to provide informed consent
• Sufficient knowledge of the German language in speech and writing
• Willingness to complete the questionnaires

Exclusion Criteria

hormone-dependent tumors (breast cancer, endometrial cancer)
• Undiagnosed genital bleeding
• Untreated endometrial hyperplasia
• Endometriosis
• Fibroids of > 2 cm
• Pregnancy
• History of cosmetic breast surgery
• Existing or past history of venous and/or arterial thromboembolic disease (especially deep vein thrombosis, pulmonary embolism, angina, myocardial infarction)
• known thrombophilic disorders (especially protein C, protein S, or antithrombin deficiency)
• previous heart surgeries, heart disease
• acute glaucoma or prior glaucoma
• Reduced resilient skeletal system, z. B. osteoporosis, bone metastases, inflammatory joint diseases
• spinal disk disease
• Undiagnosed abdominal discomfort, chronic appendicitis, which has not been operated
• inflammation of the inner ear
• Psychiatric problems, psychosis without adequate treatment

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Changes of main symptoms and well-being as measured by the Measure Yourself Concerns and Wellbeing (MYCAW) and the WHO - 5 Index before and after participating in a 10-weeks class of hormone-yoga
Secondary Outcome Measures
NameTimeMethod
Possible changes in hormone levels (FSH, LH, estradiol, TSH, T4, prolaktin, testosteron, DHEAS, progesteron during luteal Phase if applicable) before and after participating in a 10-weeks class of hormone-yoga
© Copyright 2025. All Rights Reserved by MedPath